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Abstract 
Advances in three-dimensional (3D) cell cultures offer new opportunities in biomedical 
research and drug development. However, there are still challenges to overcome, 
including the lack of reliability, repeatability and complexity of tissues obtained by these 
techniques. In this study, we describe a new bioprinting system called Reactive Jet 
Impingement (ReJI) for the bioprinting of cell-laden hydrogels. Droplets of gel precursor 
solutions are jetted at one another such that they meet and react in mid-air before the gel 
droplets fall to the substrate. This technique offers a combination of deposition rate, cell 
density and cell viability which is not currently matched by any other bioprinting 
technique. The importance of cell density is demonstrated in the development of bone 
microtissues derived from immortalized human bone marrow stem cells. The cells were 
printed with high viability within a collagen-alginate-fibrin gel, and tissue specific gene 
expression shows significantly higher tissue maturation rates using the ability of the ReJI 
system to deposit gels with a high cell density. 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
In vitro assays must effectively recapitulate the human environment in order to provide 
value in the understanding of biological processes. However, many in vitro models 
remain two-dimensional, despite 2D models being unable to simulate the human 
environment [1, 2]. Gene expression, metabolic activity, cell physiology and morphology 
and spatial organization are all affected by cells being in 2D rather than 3D, and the use 
of 2D cultures has been cited as one reason for the large attrition rate in drug trials [3, 4].  
Three-dimensional cell culture techniques allow the reproduction of the cell physiological 
environment [1-4]. Spheroids, organoids, organs-on-chips or scaffold-based cell cultures 
[5-10] constitute some of the novel 3D systems that can emulate natural cell-cell 
interactions. Scaling-up the rate of production of these structures could offer improved in 
vitro drug assays that would grant an increase in reliability and repeatability of pre-
clinical screening. Additionally, the ability to mimic the human microenvironment could 
allow a decrease in animal testing, whilst at the same time lowering cost and accelerating 
the process. However, each 3D cell culture system carries its own advantages and 
disadvantages, but generally present problems over reliability and repeatability, but also 
in terms of tissue complexity [11-14].  
Furthermore, advances in tissue engineering, biomaterials and additive manufacturing 
have enabled rapid development of bio-inspired three-dimensional structures. 
Microtissues or organ-like structures, such as mini-livers [15, 16], urethras [17] or 
muscles [18], have recently been developed by different bioprinting techniques. Currently, 
to obtain 3D structures, the most used bioprinting techniques are drop-on-demand (DoD) 
printing (inkjet and microvalve printing) and microextrusion bioprinting. The first relies 
in a system that through the activation of a piezoelectric crystals, heating nozzle or 
mechanical valves, to produce droplets with volumes ranging from pL to µL [19]. On the 
other hand, microextrusion printing uses pneumatic or mechanical systems to extrude 
continuous filaments of material [19, 20]. DoD printing techniques allow printing with 
high level of accuracy and speed, depositing hundreds to thousands of pL to nL droplets 
per second. However, inkjets commonly suffer nozzle blockage due to cell aggregation 
and, therefore, high cell densities are not generally possible. Both inkjet and microvalve 
methods are restricted to low viscosity materials (3-30 mPa/s) with a crosslinking step 
necessary to produce solid 3D structures. On the other hand, microextrusion bioprinting 
allows the printing of physiological cell densities, but it is a slow process and cells suffer 
high shear stress, resulting in increased cell death [19,20]. 
High cell density encapsulation is essential to develop tissue like cell-cell interactions 
[21]. However, obtaining physiological cell densities remains one of the biggest issues to 
achieve microtissues through bioprinting. One of the most famous concepts to develop 
tissue-like structures is “tissue spheroids as building blocks”, where hundreds of 
spheroids, carrying thousands of cells are disposed in a certain shape to fuse together 
forming a tissue [22]. This allows macroscopic specimens, such as cardiac patches [23], 
vascular or nerve grafts, to be produced [24]. However, spheroids present several 
downsides, such as long-term cell culture problems and repeatability issues [25,26]. 
Advances in extrusion bioprinters and in-house techniques have allowed higher cell 
densities, obtaining cartilaginous tissue by using 20x106 cells/mL nanocellulose bio-inks 
[27] or by adopting 40x106 cells/mL multi-material bio-inks [18]. On the other hand, bone 
constructs were developed from 8x106 cells/mL gel-loaded microcarriers bio-inks [28]. 
However, the number of reported studies with high cell densities is still scarce due the 
difficulty inherent in the bioprinting of these bio-inks.  
Here, we report for the first time a new printing system entitled Reactive Jet Impingement 
(ReJI), that combines the speed and accuracy of the DoD printing with the ability of 
depositing physiological cell densities. We show the functionality of our bioprinting 
technique by printing highly viable cell-laden collagen/alginate/fibrin hydrogels that 
allow long-term cell culture. We also show that, when human mesenchymal stromal cells 
(MSCs) are printed at high densities, they rapidly differentiate towards bone and produce 
highly organized tissue structures with mineralisation and tissue-specific gene expression 
in less than 14 days.  
 
  
2. Materials and methods 
 
2.1. Reagents 
Unless otherwise stated, reagents were obtained from Sigma-Aldrich, Gillingham, UK.  
 
2.2. Cell Culture 
Immortalized human bone marrow stem cells using human telomerase reverse 
transcriptase (BMSC-hTERT) (kindly donated by Professor Paul Genever, York 
University [29]), were grown in high-glucose with pyruvate Dulbecco's Modified Eagle's 
Medium (DMEM; Life Technologies, Carlsbad, USA) supplemented with 10% fetal 
bovine serum (FBS; Thermo Fisher Scientific, Loughborough, UK) and 5000 U/mL 
penicillin/streptomycin at 37 °C and 5% CO2. For osteogenic medium, the same DMEM 
preparation was supplemented with L-Ascorbic acid 2-phosphate sesquimagnesium salt, 
ß-Glycerophosphate, and Dexamethasone, at a final concentration of 50 µg/mL, 5 mM, 
and 10 nM, respectively. Medium was changed every 3 days during incubation periods. 
 
2.3. Preparation of gel precursors 
CAF hydrogels were optimised from the original research reported by Montalbano et al 
[30]. Prior to the pre-gel solution preparation, a 37.5 mg/mL fibrinogen (from bovine 
plasma - Type I-S, 65-85% protein (≥75% of protein is clottable)) solution was obtained 
by gently dissolving fibrinogen in Dulbecco’s Phosphate Buffered Saline (DPBS) without 
calcium and magnesium at 37 °C. A 25 mg/mL NaAlg in DPBS without calcium and 
magnesium solution was also formulated. To achieve the pre-gel solution, the fibrinogen 
and NaAlg solutions were slowly mixed, followed by carefully mixing of the prior 
preparation with 6 mg/mL pepsin soluble collagen solution in HCl (Collagen Solutions, 
Glasgow, UK) to a ratio of 1:2:8 of collagen, alginate and fibrinogen (CAF), respectively. 
As crosslinking solution, a 500 U/mL of thrombin (40-300 NIH units/mg protein) 
dissolved in high-glucose with pyruvate DMEM with 0.1% of CaCl2 was used.  
 
2.4. Printing apparatus 
A Jetlab 4 (Microfab Technologies, Inc., Plano, USA) was adapted to our in-house 
printhead (ReJI) [31]. The ReJI system was composed by two solenoid valves 
INKX0514950A – microvalves – (The Lee Company, Westbrook Center, USA) located 
in opposite sides at 55º of inclination, connected to two spike and hold drivers (The Lee 
Company) to control the open and closure of the valves. The microvalves were also 
connected to the ink loading reservoirs, which are attached to the pneumatics controller 
CT-PT4 (Microfab Technologies, Inc.). Droplet ejection was obtained by applying an 
electrical impulse in the form of a rectangular waveform with a dwell time, amplitude and 
frequency of 800 µs, 5 V and 400 Hz.  
 
2.5. Compression and degradation tests 
Compression tests were performed using a tensile tester EZ-SX (Shimadzu, Kyoto, Japan) 
equipped with a 20 N load cell. Samples were cut to a parallelepiped-like shape with a 
dimension average of 6.5x6.5x3.3 mm. The crosshead speed was set at 1 mm·min−1 and 
the tests were carried at room temperature. Compressive modulus was calculated on the 
linear elastic regime (in the range 10-20%). Then, CAF hydrogel degradation was 
obtained through gravimetric analysis. Once printed, each sample was wiped with filter 
paper and weighted (Wi) before immersion in high-glucose with pyruvate DMEM at 37 
ºC and 5% CO2 for 1, 3, 7, and 14 days. After the test end, samples were dried with filter 
paper to remove the excess of medium and reweighted (Wf). The degradation was 
calculated using the equation 1: 
𝐷𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 (%) = 1 −
𝑊𝑓
𝑊𝑖
× 100           Equation 1 
 
2.6. Glucose uptake  
A 0.06845 mg/mL 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose 
(2-NBDG; Thermo Fisher Scientific) in PBS was prepared and protected from light. After 
washing the samples with PBS, 2 mL 2-NBDG solution was added to each gel during 
different time-points. Once reached the time-point, gels were transferred to a new well-
plate with PBS to release the absorbed 2-NBDG. The resultant was read at an 
excitation/emission of 465/540 nm using a LS-50B Luminescence Spectrometer (Perkin 
Elmer, Waltham, USA). 
 
2.7. Cell-loaded CAF gels printing 
To obtain cell suspensions with 4x106 cells/mL and 40x106 cells/mL, after a DPBS wash, 
MSCs were detached with 0.25% trypsin solution, centrifuged at 1200 rpm for 5 min and 
counted. The desired cell suspension was obtained by mixing 1 mL of 500 U/mL of 
thrombin solution with 0.1% of CaCl2 with the cell pellet. The pre-gel CAF and cell-
containing crosslinking solution were loaded at 37 ºC into two reservoirs and the cell-
filled hydrogels were fabricated by simultaneous droplet jetting from each precursor that, 
when mixed in air, formed a gel before reaching the stage. To jet the pre-gel and cell-
containing crosslinking solution, the pressure system was in the range of 270–310 mmHg 
and 450–550 mmHg, respectively. A specific pattern was achieved by coding and loading 
a script into the Jetlab4 software – each 10x8 pixels and 16-layer structure was obtained 
in 4 min. After printing, the cell-laden construct was incubated in osteogenic medium at 
37 °C and 5% CO2. 
2.8. Fluorophore staining for confocal microscopy 
Cell-loaded gels were fixed immediately after printing, 7 or 14 days of incubation using 
pre-warmed 4% paraformaldehyde solution for 25 min at room temperature. Cells were 
washed three times using 0.1% DPBS/Tween 20 and phalloidin (1 mg/mL in methanol) 
added during a 40-min light-protected incubation period at room temperature. After 
further washing with 0.1% DPBS/Tween 20, 4,6-diamidino-2-phenylindole (DAPI; 
1:2500 solution, Vector Laboratories, Burlingame, USA) was added, and the solution was 
subjected to a 25-min light-protected incubation period at room temperature. Cells were 
washed and resuspended in 0.1% DPBS/Tween 20. Fixed samples were stored protected 
from light at 4 °C until visualized using a Nikon A1R (Nikon, Minato, Japan) at 10× 
magnification. 
 
2.9. Morphology study by scanning electron microscopy 
The cell morphology in the hydrogels was examined using a Tescan Vega LMU (Tescan, 
Cambridge, UK). Samples were fixed using a pre-warmed solution of 2% glutaraldehyde 
(TAAB Laboratory Equipment, Reading, UK) in Sorensons buffer. The samples were 
then stored at 4 °C overnight followed by dehydration steps using 25%, 50%, 75%, and 
100% ethanol. Samples were stored at 4 °C in 100% ethanol until critical point dried 
using a BAL-TEC 030 Critical Point Dryer (Leica Geosystems Ltd, Milton Keynes, UK). 
Finally, gels were mounted on carbon discs (TAAB Laboratory Equipment) and gold-
coated using a Polaron E5000 SEM Coating unit (Quorum Technologies Ltd (Polaron 
Division), East Sussex, UK). 
 
2.10. Cell viability, proliferation, and ALP assays 
The Live/Dead (Molecular Probes by Life Technologies, Carlsbad, USA) assay was used 
to evaluate the cell viability at different time-points. Reagent stock solutions were 
removed from the freezer and warmed to room temperature and were prepared using the 
manufacturer’s recommendations to obtain a 4 μM ethidium homodimer (EthD-1) and 2 
μM calcein AM solution. After 1h incubation at room temperature, samples were 
visualized using a Nikon A1R confocal microscope at 10× magnification. Cell 
proliferation was assessed at day 0, 7 and 14 using PicoGreen DNA quantitation assay 
(Thermo Fisher Scientific). Standards were prepared following manufacturer’s 
recommendations. After a certain time-point, samples were stored frozen (-20 ºC) in 1.5 
mL of sterile molecular biology reagent grade water. Before analysis, samples undergone 
three cycles of freezing and thawing, following 20 minutes on an ultrasonication bath to 
release all the DNA. 50 µL of the cell lysate were combined with 100 µL 1xTE and 150 
µL PicoGreen dye buffer (1:200) before loading a 96 opaque well plate in triplicates. 
After a 10-min room temperature incubation protected from light, samples were read 
(excitation/emission 485/530 nm) using a Spectramax Gemini XPS microplate reader 
(Molecular Devices, San José, USA). The ALP activity was measured using the same cell 
lysate combined with 1-Step PNPP Substrate Solution (Thermo Fisher Scientific). The 
results were compared with the dilution of a p-nitrophenol standard solution. For each 
sample, in triplicate and in a transparent 96-well plate, 80 μL of the cell lysate was 
combined with 120 μL of 1-Step PNPP Substrate Solution. After a 1-hour incubation at 
37 °C, the absorbance was read at 405 nm using a Biotek ELX800 (Biotek, Winooski, 
USA). 
 
2.11. Gene expression analysis through RT–PCR array 
RNA of cells was extracted after specific time-points using RNeasy Mini Kit (Qiagen, 
Hilden, Germany) following manufacturer’s recommendations. The extracted RNA 
concentration was measured using a Nanodrop (ND-1000, NanoDrop Technologies, 
USA). cDNA synthesis was performed using RT2 First Strand Kit (Qiagen), following 
manufacturer’s protocol. Before loading the RT-PCR Array for Human Osteogenesis 
(Qiagen), SYBR-green (Qiagen) was added to the synthetized cDNA. Gene expression 
was analysed using a ViiA7 384-well block (Applied Biosystems, Foster City, USA). 
 
2.12. Statistical analysis 
Data are expressed as mean ± standard deviation. Mean values and standard deviations 
were calculated from three independent experiments of triplicates per group. 
Comparisons were performed by one-way analysis of variance (ANOVA) in conjunction 
with Tukey’s multiple comparison test using levels of statistical significance of P < 0.05 
(*), P < 0.01 (**), P < 0.001 (***), and P < 0.0001 (****). 
 
 
3. Results 
 
3.1. Reactive jet impingement characterisation 
The concept behind the ReJI system (figure 1) relies on two microvalves connected to 
different cartridges and directed to jet droplets so that drops can meet in mid-air and form 
a gel before reaching the stage (figure 1(b)). Each microvalve is attached to a spike and 
hold driver that is responsible for the opening and closing of the microvalve, but also 
connected to the pneumatics system and to the printer input that controls the electrical 
waveform. Through optimization of all these parameters, which are dependent on the 
material to be jetted, it is possible to achieve simultaneous droplet jetting (figure 2(a)). 
The system is enclosed inside an environmental chamber. 
  
 Figure 1.  Reactive Jet Impingement system. (a) Overview of the main components: Computer, 
pneumatics controller, bench power supply connected to a spike and hold driver and a jetlab4 
printer. (b) Illustration of the ReJI printhead, which is composed by two microvalves, located in 
opposite sides, connected to a spike and hold driver, for electrical input controlling, and to the ink 
reservoirs. The solid gel (yellow) is formed upon mixing in mid-air between the gel-precursor 
(green) and crosslinking (red) droplets. 
The printing technique is reliable, printing gel droplets of similar sizes and at equidistant 
locations, over multiple layers (figure 2(b) and (c)). The optimised printing parameters 
for the collagen-alginate-fibrin gel used in this study are listed in figure 2(d), with 
collagen, alginate and fibrin deposited through one microvalve, and the thrombin and 
CaCl2 deposited through the other. Due to the non-cytotoxic effect of thrombin solutions 
[32] and low viscosity when compared to the gel-precursor, cells were loaded into the 
crosslinking solution. 
 
3.2. CAF hydrogel properties  
CAF hydrogels were optimised from the original research reported by Montalbano et al 
[30] and produced with nominal dimensions of 11 x 8 x 3 mm. Our first analysis tested 
the ability of acellular printed CAF hydrogels with properties suitable for cell 
maintenance during long cell culture periods. The hydrogel contains natural materials, 
including proteins, and it was necessary to guarantee that no medium component would 
affect the printed hydrogel for long time-intervals. It was established that printed 
structures showed comparable levels of degradation at different time-points, losing 
around 30% of its total mass after any incubation time-point inspected (figure 3(a)). To 
support cells inside the hydrogels, it is crucial that molecules are be able to be delivered 
to the most inner site of it. Therefore, the CAF hydrogel absorbance and molecule 
permeation capabilities has been studied using a 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-
yl)Amino)-2-Deoxyglucose (2-NBDG) solution, a fluorescent glucose analogue (figure 
3(b)). Rapid 2-NBDG uptake in the first 30 min was observed, reaching a close-to-
maximum uptake plateau between 30 and 60 min (figure 3(b)) for 3 mm thick specimens. 
The mechanical properties in compression of printed CAF gels gave a compressive 
modulus of 1120±40 Pa calculated from the linear region of the stress-strain curve, in the 
10-20% strain interval (figure 3(c)). The hydrogel microstructure was observed by 
scanning electron microscopy (SEM; figure 2(d)). A highly porous system was revealed 
by SEM images of samples at different time-points. It was observed that incubation in 
cell medium at 37°C and 5% CO2 for 14 days did not change the hydrogel structure, 
presenting a similar morphology to the freshly printed samples. Outer and inner porosity 
can be seen with more detail in supplementary figure 1. 
 
d   Material [C] 
(mg/mL) 
Frequency 
(Hz) 
Pressure 
(mmHg) 
Dwell Time 
(µs) 
 
CAF 
Col – 0.54 
NaAlg – 
4.54 
Fib – 27.27 
400 450 800 
 500 U/mL Thrombin with 
CaCl
2
 
CaCl
2
 – 
1.00 
400 290 800 
 500 U/mL Thrombin with 
CaCl
2
  
Loaded with 4x10
6
 cells/mL 
CaCl
2
 – 
1.00 
400 290 800 
 500 U/mL Thrombin with 
CaCl
2
  
Loaded with 40x10
6
 
cells/mL 
CaCl
2
 – 
1.00 
400 300 800 
 
Figure 2. ReJI printing technique. (a) Stroboscopic images of gel-precursor and crosslinking 
droplets meeting in air. CAF gel loaded with 40 x 106 cells: (b) printed in single layer droplets 
0.795±0.083 mm dia; and (c) after 2 (top) and 5 (bottom) layers, respectively. (d) Optimised 
parameters used to print hydrogel precursors using ReJI printhead. Scale bars represent 200 µm. 
 
 Figure 3. CAF gel properties. (a)  CAF gel mass loss after incubation in medium during 1 to 14 
days. Gels did not degrade, losing a maximum of 40% of its weight during the studied time-
points. (b) CAF gel glucose uptake. A plateau on the uptake of 2-NBDG was reached 30 to 60 
minutes (corresponding to 85-90% of maximum uptake) after putting the gel in contact with this 
solution. (c) Uniaxial compression of CAF gels. A compression modulus of (1.125±0,042) kPa 
was obtained for 10-20% strain interval. (d) CAF gel morphology after freeze drying. The SEM 
images show a highly porous fibre-like structure. 1 and 2 show a gel fixed immediately after 
printing and 3 and 4 reveal a gel fixed after 14 days of incubation in medium. Scale bars 
represent 1 mm. Each assay was conducted in triplicate. 
 
3.3. Printing of cell-loaded CAF hydrogels  
The ReJI printhead allowed for the rapid creation of high cell density droplet-on-demand 
printed hydrogels, with two concentrations of MSCs used: 4 and 40 million cells per mL. 
The printed hydrogels, independent of the cell number, presented identical structures with 
dimensions 11 x 8 x 3 mm after printing, however, the hydrogel was more opaque with 
the increased cell density (figure 4(a)). The cell distribution after printing was observed 
through confocal microscopy (figure 4(b)). An increment on the cell number per unit of 
area was naturally noticed, showing higher cell dispersion on 4x106 cells/mL hydrogels 
and super-confluent hydrogels when using 40x106 cells/mL inks. The encapsulated MSCs 
in CAF hydrogels had their viability evaluated by Live/Dead assay instantly after printing 
(supplementary figure 2) and after 7 and 14 days (figure 4(c) of incubation in osteogenic 
medium. Both cell densities presented almost no cell death after printing, with 
cytocompatibility maintained 7 and 14 days later. 
A PicoGreen assay was used to examine cell proliferation in the hydrogels (figure 4(d)). 
As expected, 40x106 cells/mL hydrogels presented an increased cell number on day 0, 
about (5.22±1.30)x106 cells per gel, when compared to the low-density structures, which 
had approximately 9-fold less cells, (0.61±0.03)x106. However, at day 7, a reduction in 
cell number in the high-density hydrogels and an increase in cell number in the low 
density hydrogels, led to similar cell numbers across all the samples (approximately 
2.7x106 cells per gel). At day 14, although both hydrogel constructs had higher cell 
numbers, the 40x106 cells/mL hydrogels presented the highest proliferation rate from day 
7 to 14, increasing cell numbers to (5.44±1.88)x106 cells per gel. Using the PicoGreen kit 
standards, it was possible to calculate the DNA amount per cell – 5.6 pg/cell. Alkaline 
Phosphatase (ALP) was measured for each sample over the time course. The highest 
activity was observed at day 0, with no significant difference between the high and low 
cell density hydrogels. On days 7 and 14, the ALP value has decreased two to three-fold, 
with similar concentrations of PnPP per cell in both samples. 
 
Figure 4. Cell number, viability and functionality. (a) Stereomicroscope pictures showing the 
morphology of the CAF gels loaded with 4x106 cells/mL (top) and 40x106 cells/mL (bottom) 
immediately after printing. Scale bar represents 2 mm. (b) Confocal microscopy volume stack 
showing cell distribution in CAF gels with different cell number. Scale bar represents 200 µm. (c) 
Live/Dead assay. Cell viability of MSCs after 7 and 14 days of incubation in osteogenic medium 
(live cells are represented in green and dead in red). Scale bar represents 100 µm. (d)  Cell number 
(obtained by PicoGreen assay) present in CAF gels with 4x106 and 40x106 cells/mL after 
incubation during 0, 7 and 14 days in osteogenic medium. (e) PnPP concentration per cell obtained 
from ALP assay after incubation during 0, 7 and 14 days in osteogenic medium. *, **, ***, and 
**** indicate significant difference between groups at the levels p < 0.05, p < 0.01, p < 0.001, 
and p < 0.0001, respectively. Error bars represent the standard deviation (n = 3). 
 
SEM and confocal microscopy were used to characterize the cell morphology and the 
degree of cell organization (figure 5). The images at day 0 (figure 5(a) and (b)) clearly 
illustrate the different cell densities. By day 14 the lower density gel structures change 
from random cell alignment to a more organised morphology – cell alignment starts to be 
more apparent. In the high-density gels higher orientation and contact between cells is 
observable on day 7, and the degree of this organization clearly increases on day 14, with 
the development of clear tissue-like structures.  
 
Figure 5. Cell and tissue morphology after incubation during 0, 7 and 14 days in osteogenic 
medium by confocal and scanning electron microscopy. (a) shows 4x106 cells/mL loaded gels 
with an increase on cell organization along the incubation days (Red – F-Actin; Blue – Nucleus). 
Scale bars represent 100 µm for confocal images and 10, 20, and 50 µm, respectively, for SEM 
images. (b) For 40x106 cells/mL loaded gels, cell density seems to favour cell migration, 
organisation and highly-defined tissue formation (Red – F-Actin; Blue – Nucleus). Scale bars 
represent 100 µm for confocal images and 50, 20, and 50 µm, respectively, for SEM images.  
Increased calcium deposition was observed for the higher cell density samples (figure 6(a) 
and (b)), with differentiation affected by cell density, as cuboidal cells are already 
detected in the high-density hydrogels by day 7 (figure 6(c) and (d)). This is a clear sign 
of MSC differentiation into active osteoblasts. On the other hand, for the low-density 
hydrogels, cuboidal shaped cells are only observed at day 14. 
 
 Figure 6. Calcium deposition and cell morphology after incubation during 7 and 14 days in 
osteogenic medium by scanning electron microscopy. (a) and (b)  show the calcium deposition 
on low and high cell density hydrogels, respectively (black arrows). A faster and increased 
deposition is possible to be verified on 40x106 cells/mL hydrogels. (c) and (d) demonstrate  
morphology changes during differentiation for low and high cell density samples, respectively. 
Cuboidal cells (black arrows) are already observable by day 7 on 40x106 cells/mL hydrogels. The 
same only happens after 14 days of differentiation on low cell density specimens. Scale bars 
represent 10 µm ((a) and (b)) and 20 µm ((c) and (d)). 
3.4. Osteogenic specific gene expression 
Cells from the hydrogels were analysed for osteogenic specific genes using an RT-PCR 
array. At the lower cell density, it was observed that encapsulated cells showed higher 
expression of 48 genes (24 genes for skeletal development and 7 for bone mineral 
metabolism), with lower expression of 24 genes (11 genes correspond to skeletal 
development and 2 for bone mineral metabolism) at day 14, when compared to day 0 
(figure 7(a)). Several markers of osteogenic differentiation had increased expression, 
including RUNX2 (more than 2-fold), SP7 (1.5-fold exchange), and BMP-2 (7.22-fold) 
(figure 7(c)). Reduced expression was observed for ALP, BGLAP and SPP1.  
Hydrogels at the higher cell density showed increased expression of 67 genes (36 genes 
for skeletal development and 11 for bone mineral metabolism) over the 14-day period, 
with reduced expression of 22 genes (9 genes for skeletal development and 2 for bone 
mineral metabolism; figure 7(b)). The increased expression of RUNX2 (over 10-fold), 
SPP1 (higher than 7-fold), BMP-2 (over 300-fold), and BMP-6 (250-fold) were 
particularly notable (figure 7(d)). ALP and BGLAP showed reduced expression over the 
time course.  
Finally, comparing the high and low cell density hydrogels at day 14, the higher density 
gel showed markedly increased expression of osteogenic biomarkers when compared to 
the lower density gel: RUNX2 (over 2.5-fold increase), SPP1 (nearly 15-fold) and 
BMP-2 (45-fold), BMP-3 (2-fold), BMP-6 (nearly 60-fold) and BMP-7 (4-fold). 
Contrarily, SP7, ALP and BGLAP, showed lower expression when comparing the high 
to low density gels at day 14.  
 
4. Discussion 
The ReJI system is the first drop-on-demand bioprinting system that can deposit cell-
laden hydrogels with a high cell density. Impingement mixing is not a new concept, it has 
long been exploited for mixing air flows [33], and in the reactive injection moulding 
process to mix molten polymers [34]. In printing applications impingement mixing of 
droplets was first proposed for colour inkjet mixing [35]. There are also examples of twin 
valve or jet systems being used for bioprinting: with two adjacent valves being used with 
an on-substrate reaction [36], or to deliver two types of cell onto a surface [37]. GESIM 
offer a twin piezo system (TwinTip) for creating arrays of gel droplets on their Nano-
plotter, and Visser et al report on the jetting of droplets into a stream of crosslinking 
solution to create encapsulated spheroids [38]. The unique elements of the ReJI system 
are that it offers a drop on demand system based on micro-valves, and these elements 
allow the system to 3D print high cell density gels.   
 
 
 
 
 
Figure 6. Osteogenic gene expression. (a) and (b) shows  the gene expression comparison 
between 4M d14 to 4M d0, and 40M d14 to 40M d0. (c)-(e)exhibit the fold change of some of the 
most important osteogenic gene, comparing 4M d14 to 4M d0, 40M d14 to 40M d0, and 40M d14 
to 4M d14, respectively. At day 14, 40x106 cells/mL loaded gels present gene expression that 
reflects mature osteoblast formation, contrarily to 4x106 cells/mL loaded gels that show pre-to-
early osteoblast related gene expression.  
The limitations of the ReJI process are that the system relies on rapid crosslinking to 
create gel droplets above the substrate, and that, as configured for this work, it is relatively 
low resolution, ~0.5-0.8 mm.  The resolution of the system could be improved by using 
valves or jets with smaller orifices, but this would be expected reduce the upper limit in 
terms of achievable cell density. Table 1 compares our in-house technique to other 
common bioprinting techniques, to demonstrate that the system uniquely offers high cell 
density, with high cell viability, within a viscous gel, at high volume deposition rates.  
Beyond jetting approaches, the Kenzan method [39], offers the most automated way of 
creating high cell density constructs, assembling pre-made cell spheroids to create tissue. 
Cell spheroid assembly delivers functional tissue without the need for a scaffold, but does 
require the generation of the spheroids prior to assembly. ReJI offers a process which 
delivers a lower cell density than cell spheroid assembly, but where the cell density is 
such that the cell-to-cell contact essential for tissue maturation is established in the printed 
gel. The use of ReJI for tissue development will require scaffolds, but it offers an 
alternative process for high cell density tissue pre-cursor development which does not 
require the generation of spheroids as a first step. The morphology shown in Figure 5 
indicates that dense tissue-like structures are formed, along with spaces in the micro-
tissue, which may arise from greater contractile forces in the high cell density gel, 
analogous to the contraction seen in spheroid development. Further work will be required 
to assess the relative productivity and efficiency of the alternative approaches to creating 
high cell density constructs.  
Table 1 – Comparison between ReJI and other bioprinting techniques. Numbers are based on what 
is achievable for one deposition unit. 
 
ReJI 
bioprinting 
Inkjet 
bioprinting 
Single 
microvalve 
bioprinting 
Extrusion 
bioprinting 
Laser-
assisted 
bioprinting 
Ref. 
Viscosity of 
Material 
Deposited 
on the 
Substrate 
1–70 
mPa/s 
3–30 
mPa/s 
1–70 mPa/s 
30 mPa/s 
to >6x107 
mPa/s 
 
1–300 mPa/s 
 
19, 20, 
40 
Printing 
Speed 
6 500 
droplets/s 
1 – 10 000 
droplets/s 
6 500 
droplets/s 
10 µm/s – 
700 mm/s. 
100 – 5000 
droplets/s 
19, 20, 
41-47 
Volume 
deposition 
rate 
80 µL/s 160 µL/s 40 µL/s 3-15 µL/s  
175 - 1800 
nL/s 
41, 47-50 
Resolution 
100-300 
nL 
droplets 
pL 
droplets 
pL to nL 
droplets 
5 µm to 
mm size 
deposited 
track 
<pL 
droplets 
19, 46 
Cell 
viability 
>90% >85% >90% 40-80% >95% 19, 46 
Crosslinking 
Process 
In process 
Post-
printing 
Post-
printing 
Pre-, post- 
printing 
Post-
printing 
19, 42 
Cell density 
9x107 
cells/mL 
Low, 
<5x106 
cells/mL 
High, 
107/mL 
High, cell 
spheroids 
High, 108 
cells/mL 
19, 20, 
46 
To obtain the developed microtissues, 14 days of incubation in osteogenic medium at 
37°C and 5% CO2 was necessary. The 30% hydrogel mass loss may be connected to 
poorly crosslinked branches inside the CAF gel structure being washed off during the 
incubation period. The 3 mm thick CAF hydrogel was able to quickly absorb dissolved 
molecules with saturation in less than 1 hour. This guarantees stability of cells during 
their development. The interconnected porous network in the gel is essential for building 
up microtissues based on high cell densities, as cell migration will be necessary for tissue 
development [51-53]. This porous network is preserved over a 14-day period, making this 
hydrogel ideal for tissue development applications. 
Cells survive the jetting and impingement processes. This is explained by the low 
viscosity of both cell carrier ink (crosslinking solution) and gel precursor. When leaving 
the microvalve nozzle, cells suffer little shear stress due to the low viscosity of the 
crosslinker solution. Additionally, when mixing, the fast reaction instantly encapsulates 
the cells, giving them protection when droplet reaches the substrate, but also assuring 
elasticity (that fibrin enriched hydrogels are recognized for [54,55]) to minimize stress on 
impact. The impingement and quick reaction are a pre-requisite for forming well defined 
multi-layer structures. The modulus obtained for the acellular bioprinted gel (1.1 kPa) is 
very similar to the modulus of similar gel formulations when prepared conventionally 
(0.9-1.3kPa)  [30]. One and two weeks after printing, cell viability is maintained, as fibrin 
and collagen are biocompatible natural materials that are widely used as scaffold 
materials due to their properties, including extracellular matrix promotion [56,57]. 
Precise structures were printed using two different cell density inks, producing hydrogels 
with an average of 6x105 and 5x106 cells for the low and high cell density hydrogels, 
respectively.  
Cell detachment is considered as the main reason for cell number decrease on high cell 
density hydrogels on day 7. The cell numbers reported in Figure 4 are the numbers of 
cells in the gel. In the high cell population gels some cells migrate out of the gel into the 
surrounding media, which means that we have three main cellular mechanisms operating 
in parallel. For the high cell density gel migration and differentiation seem to dominate 
in week 1, while in week 2 proliferation and differentiation dominate. This cell migration 
out of the gel is not necessarily a bad thing, as the benefit of having a highly confluent 
gel is clearly seen in Figs 5-7. Contrarily, for the low cell density hydrogels, proliferation 
seems to be the dominant mechanism in week 1, with differentiation in week 2. 
Microtissue development is dependent on several factors, including cell density, 
mechanical forces and the presence of extracellular matrix [58-62]. Here, we reinforce 
past studies, with special focus on the importance of high cell densities in 3D structures 
to obtain fast and developed microtissues by direct differentiation [15, 57, 63].  
Increased calcium deposition on the higher cell density hydrogels is assumed to be a result 
of a faster rate of MSC differentiation into osteoblasts. This was confirmed by the 
presence of cuboidal cells, a morphology which is associated with mature osteoblasts [64], 
already by day 7. ALP, an early osteogenic marker, supports this view. Increased ALP 
concentrations were produced at day 0, when compared to day 7 and 14, with the higher 
cell density hydrogels presenting the lowest concentration at day 14, as ALP levels are 
downregulated by the end of the osteogenesis [65, 66].  
Gene expression was also influenced by cell density. Typical pre-osteoblastic behaviour 
was observed on low cell density hydrogels due to the increased expression of RUNX2 
and SP7 and reduced expression of BGLAP and SPP1 [67]. BMPs, intrinsically connected 
to bone formation, also increased expression.  
This work has shown that cell density is crucial to the rate of functional bone microtissue 
formation. In cancer and in other diseases there is a clear commercial need for improved 
models for large scale screening, and microtissue models are considered to offer 
significant potential [68,69]. To date the scalability and reliability of microtissue models 
has been identified as limitations, with these issues closely related [14,70]. A lack of 
scalability means that limited replicates of any given experiment can be made, and a lack 
of replicates makes it difficult to understand variation in statistical terms.  By reliably 
depositing cells and materials at rates which allow for thousands of micro-tissue 
precursors to be generated per hour the ReJI technology has potential to address a key 
problem in terms of micro-tissue model development and exploitation. Future work will 
address understanding the limits in terms of resolution, integrating the technique with 
scaffold manufacturing processes to create composite tissue engineered structures, and 
use of the technique to create co-cultures at high throughput rates.  
 
5. Conclusion 
This study describes the development and characterisation of high cell density cell-
laden hydrogels produced via reactive jet impingement. The fabricated CAF hydrogels 
presented high uptake capability, which is essential for cell maintenance, and porous 
structures, that were conserved after 14-days of incubation. The hydrogels supported 
cell viability, proliferation, migration and promoted osteogenic differentiation of 
bMSCs. The ReJI system was able to printing bio-inks with a cell density of 40x106 
cells/mL. Cell density was revealed to be key for microtissue formation through 
assessment of osteogenic specific markers, as well as to the increased deposition of 
calcium. In addition, cell differentiation was demonstrated to be faster at higher cell 
densities cell-laden hydrogels. The ReJI process offers a new and valuable approach to 
bioprinting with high cell density gels. 
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